{
  "context": {
    "rules": [
      "Rule1: Provided that Phase 2 is successful for drug Alpha, then FDA approval for drug Alpha occurs.",
      "Rule2: Whenever Phase 3 is successful for drug Alpha, then FDA approval for drug Alpha follows.",
      "Rule3: If production is scaled for drug Alpha, then manufacturing is ready for drug Alpha.",
      "Rule4: Under the condition that emergency approval occurs for drug Alpha, then either Phase 2 is successful for drug Alpha or Phase 3 is successful for drug Alpha.",
      "Rule5: Either a pandemic outbreak happens for influenza X or a seasonal outbreak happens for influenza X.",
      "Rule6: Under the condition that a seasonal outbreak occurs for influenza X, then emergency approval occurs for drug Alpha.",
      "Rule7: Either WHO declares an emergency for influenza X or CDC declares an emergency for influenza X.",
      "Rule8: If CDC declares an emergency for influenza X, then whenever a pandemic outbreak of influenza X occurs, production is scaled for drug Alpha.",
      "Rule9: Under the condition that mass production is authorized for drug Alpha, then production is scaled for drug Alpha.",
      "Rule10: Provided that the distribution network is activated for drug Alpha, then mass production is authorized for drug Alpha.",
      "Rule11: Whenever drug Alpha's patent is extended, then market exclusivity is granted for drug Alpha.",
      "Rule12: Provided that safety concerns are raised for drug Alpha, then if it is not the case that drug Alpha is FDA-approved, then treatment is restricted for drug Alpha.",
      "Rule13: If efficacy concerns are raised for drug Alpha, then under the condition that drug Alpha is not FDA-approved, then treatment is restricted for drug Alpha.",
      "Rule14: Provided that adverse events are reported for drug Alpha, then safety concerns are raised for drug Alpha.",
      "Rule15: Either adverse events are reported for drug Alpha or drug Alpha has clinical failures.",
      "Rule16: Under the condition that animal studies are successful for drug Alpha, then preclinical tests are passed for drug Alpha.",
      "Rule17: Either animal studies are successful for drug Alpha or in-vitro tests are passed for drug Alpha.",
      "Rule18: Provided that drug Alpha has clinical failures, then statistical significance is not met for drug Alpha.",
      "Rule19: If statistical significance is not met for drug Alpha, then efficacy concerns are raised for drug Alpha.",
      "Rule20: Under the condition that competitor drugs exist for drug Alpha, then alternative therapies are available for drug Alpha.",
      "Rule21: Provided that public health need is high for influenza X, then if it is not the case that when WHO declares an emergency for influenza X, then if a pandemic outbreak of influenza X happens, production is scaled for drug Alpha, then competitor drugs exist for drug Alpha.",
      "Rule22: Either influenza X has a high mortality rate or influenza X has a high transmission rate.",
      "Rule23: Provided that influenza X has a high transmission rate, then public health need is high for influenza X.",
      "Rule24: Under the condition that contradictory evidence exists for drug Alpha, then there is consensus among experts for drug Alpha.",
      "Rule25: If contradictory evidence exists for drug Alpha, then it is not the case that there is consensus among experts for drug Alpha.",
      "Rule26: Either contradictory evidence exists for drug Alpha or, if influenza X has a high mortality rate, then public health need is high for influenza X.",
      "Rule27: Whenever drug Alpha completes Phase 1, then the clinical trial is approved for drug Alpha.",
      "Rule28: If drug Alpha is FDA-approved, then influenza X is a global health priority.",
      "Rule29: Provided that it is not the case that when WHO declares an emergency for influenza X, then if a pandemic outbreak of influenza X happens, production is scaled for drug Alpha, then drug Alpha's stockpile is insufficient.",
      "Rule30: Provided that it is not the case that when WHO declares an emergency for influenza X, then under the condition that a pandemic outbreak of influenza X occurs, production is scaled for drug Alpha, then it is not the case that alternative therapies are available for drug Alpha.",
      "Rule31: Whenever it is not the case that either drug Alpha is in the traditional approval process or, if regulatory fast track is in effect for drug Alpha, then under the condition that a pandemic outbreak of influenza X occurs, the distribution network is activated for drug Alpha, then drug Alpha's patent is extended.",
      "Rule32: Provided that it is not the case that either drug Alpha is in the traditional approval process or, if regulatory fast track is in effect for drug Alpha, then whenever a pandemic outbreak of influenza X happens, the distribution network is activated for drug Alpha, then it is not the case that market exclusivity is granted for drug Alpha.",
      "Rule33: Under the condition that it is not the case that if in-vitro tests are passed for drug Alpha, then provided it is not the case that influenza X is a global health priority, then drug Alpha does not have severe side effects, then drug Alpha's compound is toxic.",
      "Rule34: If it is not the case that provided in-vitro tests are passed for drug Alpha, then under the condition that influenza X is not a global health priority, then drug Alpha does not have severe side effects, then drug Alpha's compound is safe.",
      "Rule35: Under the condition that it is not the case that whenever drug Alpha's compound is safe, then drug Alpha's compound is not toxic, then drug Alpha completes Phase 1.",
      "Rule36: Provided that it is not the case that influenza X is a global health priority, then drug Alpha has severe side effects."
    ],
    "facts": [
      "Fact1: Drug Alpha is on regulatory fast track.",
      "Fact2: It is not the case that manufacturing is ready for drug Alpha.",
      "Fact3: It is not the case that drug Alpha's stockpile is insufficient.",
      "Fact4: Drug Alpha did not pass preclinical tests.",
      "Fact5: It is not the case that drug Alpha is in the traditional approval process.",
      "Fact6: Treatment is not restricted for drug Alpha.",
      "Fact7: The clinical trial is not approved for drug Alpha."
    ]
  },
  "question": "Influenza X is a global health priority."
}